SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-10-008880
Filing Date
2010-02-23
Accepted
2010-02-23 16:57:54
Documents
4
Period of Report
2010-02-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a10-4244_18k.htm 8-K 48270
2 EX-10.1 a10-4244_1ex10d1.htm EX-10.1 518385
3 EX-99.1 a10-4244_1ex99d1.htm EX-99.1 10166
4 GRAPHIC g42441mmi001.gif GRAPHIC 5046
  Complete submission text file 0001104659-10-008880.txt   585572
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 7000 SHORELINE COURT SUITE 270 SO. SAN FRANCISCO CA 94080 2062862501
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16614 | Film No.: 10627116
SIC: 2834 Pharmaceutical Preparations